This is the authors' abstract. We don't add key points for this paper.
The Cover Feature shows the conceptual conversion of clinafloxacin to its tetracyclic analog by addition of a 7-membered ring, thereby conformationally fixing the amino-pyrrolidine ring out of plane from the bicyclic quinolone core. The compound is shown bound to one of its targets, topoisomerase IV from S. pneumoniae (PDB 4kpf, I. Laponogov et al., Open Biol. 2016, 6, DOI: 10.1098/rsob.160157) and stacking to its DNA template, depicted schematically in orange. The modification of this fluoroquinolone core resulted in a remarkable enhancement of microbiological potency toward both Gram-positive and Gram-negative bacteria. This presents an excellent advantage in our fight against multidrug-resistant bacteria. More information can be found in the Communication by Heinz E. Moser et al. on page 1687 in Issue 20, 2017 (DOI: 10.1002/cmdc.201700426).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wagman et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: